Vivos Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $423.0K | $16.9M | $18.2M |
| FY2021 | $1.3M | $25.5M | $24.0M |
| FY2022 | — | $4.8M | $3.5M |
| FY2023 | — | $411.0K | $1.6M |
| FY2024 | — | $8.0M | $6.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $423.0K | $16.9M | $18.2M |
| FY2021 | $1.3M | $25.5M | $24.0M |
| FY2022 | — | $4.8M | $3.5M |
| FY2023 | — | $411.0K | $1.6M |
| FY2024 | — | $8.0M | $6.3M |